Table 1.

Patient demography, vascular risk factors and Fazekas scores in MB-positive and MB-negative patients with AD or DLB (see text for discussion)

	n	Age years	Men %	HDSR	HBP %	DM %	Dyslipid %	Af %	Plt %	PVH	WMH
MB(+) AD	16	78.4 ± 5.3	56	18.1 ± 6.9	69	25	19	6	25	1.75 ± 0.86	1.56 ± 0.81
MB(–) AD	65	79.8 ± 5.4	45	18.8 ± 5.3	57	34	28	5	12	1.26 ± 0.69	0.86 ± 0.70
P		0.29	0.29	0.85	0.29	0.36	0.35	0.59	0.18	0.03	0.002
MB(+) DLB	10	81.0 ± 3.3	60	20.6 ± 5.2	70	10	0	0	20	1.80 ± 0.42	1.50 ± 0.85
MB(–) DLB	49	77.5 ± 6.2	39	16.5 ± 7.2	45	35	12	0	4	1.31 ± 0.59	0.96 ± 0.64
P		0.04	0.19	0.10	0.14	0.12	0.31	–	0.13	0.005	0.03
Plt = Antiplatelet agents.